Tetramethylpyrazine and Paeoniflorin Inhibit Oxidized LDL-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells via VEGF and Notch Pathways

<div>Analysis of the effects of combination treatment and Notch inhibitor treatment on ox-LDL-induced angiogenesis. Protein expression levels of (a) VEGFR2, (b) Notch1, (c) Jagged1, and (d) Hes1 were analyzed by western blot. Values are means ± SD. #<i>P </i>&lt; 0.05 versus ox-LDL-induced group. (e) Protein extracts were immunoblotted to determine the relative expression levels of VEGFR2, Notch1, Jagged1, and Hes1.</div>

Evidence-Based Complementary and Alternative Medicine

fig8

Figure 8

Figure 8: Tetramethylpyrazine and Paeoniflorin Inhibit Oxidized LDL-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells via VEGF and Notch Pathways 

Figure 8 | Tetramethylpyrazine and Paeoniflorin Inhibit Oxidized LDL-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells via VEGF and Notch Pathways 